• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经元中线粒体稳态调节的分子机制及阿尔茨海默病的潜在治疗方法。

Molecular mechanisms of mitochondrial homeostasis regulation in neurons and possible therapeutic approaches for Alzheimer's disease.

作者信息

Ren Jiale, Xiang Beibei, Xueling Lin, Han Xiaolu, Yang Zhen, Zhang Mixia, Zhang Yanjun

机构信息

School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, China.

Medical Experiment Center, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.

出版信息

Heliyon. 2024 Aug 17;10(17):e36470. doi: 10.1016/j.heliyon.2024.e36470. eCollection 2024 Sep 15.

DOI:10.1016/j.heliyon.2024.e36470
PMID:39281517
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11401100/
Abstract

Alzheimer's disease (AD) is a neurological disease with memory loss and cognitive decline, which affects a large proportion of the aging population. Regrettably, there are no drug to reverse or cure AD and drug development for the primary theory of amyloid beta deposition has mostly failed. Therefore, there is an urgent need to investigate novel strategies for preventing AD. Recent studies demonstrate that imbalance of mitochondrial homeostasis is a driver in Aβ accumulation, which can lead to the occurrence and deterioration of cognitive impairment in AD patients. This suggests that regulating neuronal mitochondrial homeostasis may be a new strategy for AD. We summarize the importance of mitochondrial homeostasis in AD neuron and its regulatory mechanisms in this review. In addition, we summarize the results of studies indicating mitochondrial dysfunction in AD subjects, including impaired mitochondrial energy production, oxidative stress, imbalance of mitochondrial protein homeostasis, imbalance of fusion and fission, imbalance of neuronal mitochondrial biogenesis and autophagy, and altered mitochondrial motility, in hope of providing possible therapeutic approaches for AD.

摘要

阿尔茨海默病(AD)是一种伴有记忆丧失和认知衰退的神经疾病,影响着很大一部分老年人群。遗憾的是,目前尚无药物能够逆转或治愈AD,而且针对淀粉样β蛋白沉积这一主要理论的药物研发大多以失败告终。因此,迫切需要研究预防AD的新策略。最近的研究表明,线粒体稳态失衡是Aβ积累的一个驱动因素,这可能导致AD患者认知障碍的发生和恶化。这表明调节神经元线粒体稳态可能是治疗AD的一种新策略。在本综述中,我们总结了线粒体稳态在AD神经元中的重要性及其调节机制。此外,我们总结了有关AD患者线粒体功能障碍的研究结果,包括线粒体能量产生受损、氧化应激、线粒体蛋白质稳态失衡、融合与裂变失衡、神经元线粒体生物发生和自噬失衡以及线粒体运动改变,希望能为AD提供可能的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1900/11401100/e8645f3edc21/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1900/11401100/1ccaf4663742/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1900/11401100/34149b7897f8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1900/11401100/e8645f3edc21/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1900/11401100/1ccaf4663742/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1900/11401100/34149b7897f8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1900/11401100/e8645f3edc21/gr3.jpg

相似文献

1
Molecular mechanisms of mitochondrial homeostasis regulation in neurons and possible therapeutic approaches for Alzheimer's disease.神经元中线粒体稳态调节的分子机制及阿尔茨海默病的潜在治疗方法。
Heliyon. 2024 Aug 17;10(17):e36470. doi: 10.1016/j.heliyon.2024.e36470. eCollection 2024 Sep 15.
2
Mitochondrial Dysfunction as a Driver of Cognitive Impairment in Alzheimer's Disease.线粒体功能障碍作为阿尔茨海默病认知障碍的驱动因素。
Int J Mol Sci. 2021 May 3;22(9):4850. doi: 10.3390/ijms22094850.
3
Inhibition of Drp1 Ameliorates Synaptic Depression, Aβ Deposition, and Cognitive Impairment in an Alzheimer's Disease Model.抑制动力相关蛋白1可改善阿尔茨海默病模型中的突触抑制、β淀粉样蛋白沉积和认知障碍。
J Neurosci. 2017 May 17;37(20):5099-5110. doi: 10.1523/JNEUROSCI.2385-16.2017. Epub 2017 Apr 21.
4
Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.淀粉样β和磷酸化 tau 诱导的阿尔茨海默病中的自噬和 mitophagy 缺陷。
Cells. 2019 May 22;8(5):488. doi: 10.3390/cells8050488.
5
Precursor-Independent Overproduction of Beta-Amyloid in AD: Mitochondrial Dysfunction as Possible Initiator of Asymmetric RNA-Dependent βAPP mRNA Amplification. An Engine that Drives Alzheimer's Disease.阿尔茨海默病中β-淀粉样蛋白的前体非依赖性过量产生:线粒体功能障碍作为不对称RNA依赖性β-淀粉样前体蛋白(βAPP)mRNA扩增的可能引发因素。一种驱动阿尔茨海默病的机制
Ann Integr Mol Med. 2019;1(1):61-74. Epub 2019 Nov 20.
6
Alzheimer's Disease is Driven by Intraneuronally Retained Beta-Amyloid Produced in the AD-Specific, βAPP-Independent Pathway: Current Perspective and Experimental Models for Tomorrow.阿尔茨海默病由在AD特异性、β-淀粉样前体蛋白(βAPP)非依赖途径中产生并在神经元内保留的β-淀粉样蛋白驱动:当前观点及未来实验模型
Ann Integr Mol Med. 2020;2(1):90-114. doi: 10.33597/aimm.02-1007.
7
Role of mitochondrial homeostasis and dynamics in Alzheimer's disease.线粒体稳态和动态在阿尔茨海默病中的作用。
Neurobiol Dis. 2013 Mar;51:3-12. doi: 10.1016/j.nbd.2011.12.057. Epub 2012 Jan 10.
8
Artesunate restores mitochondrial fusion-fission dynamics and alleviates neuronal injury in Alzheimer's disease models.青蒿琥酯恢复阿尔茨海默病模型中线粒体融合-分裂动力学并减轻神经元损伤。
J Neurochem. 2022 Aug;162(3):290-304. doi: 10.1111/jnc.15620. Epub 2022 May 21.
9
Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease.氧化应激、突触功能障碍与阿尔茨海默病
J Alzheimers Dis. 2017;57(4):1105-1121. doi: 10.3233/JAD-161088.
10
Dysfunctional Mitochondria and Mitophagy as Drivers of Alzheimer's Disease Pathogenesis.功能失调的线粒体与线粒体自噬作为阿尔茨海默病发病机制的驱动因素
Front Aging Neurosci. 2019 Nov 20;11:311. doi: 10.3389/fnagi.2019.00311. eCollection 2019.

引用本文的文献

1
Review of FUNDC1-mediated mitochondrial autophagy in Alzheimer's disease.阿尔茨海默病中FUNDC1介导的线粒体自噬研究综述
Front Aging Neurosci. 2025 May 12;17:1544241. doi: 10.3389/fnagi.2025.1544241. eCollection 2025.
2
Mitochondrial Fragmentation as a Key Driver of Neurodegenerative Disease.线粒体碎片化作为神经退行性疾病的关键驱动因素
Curr Alzheimer Res. 2024;21(9):607-614. doi: 10.2174/0115672050366194250107050650.

本文引用的文献

1
Role of autophagy and proteostasis in neurodegenerative diseases: Exploring the therapeutic interventions.自噬和蛋白稳态在神经退行性疾病中的作用:探索治疗干预措施。
Chem Biol Drug Des. 2024 Apr;103(4):e14515. doi: 10.1111/cbdd.14515.
2
PFASs May Risk Alzheimer's Disease.全氟烷基和多氟烷基物质可能会引发患阿尔茨海默病的风险。
J Gerontol A Biol Sci Med Sci. 2024 Mar 1;79(3). doi: 10.1093/gerona/glad277.
3
Molecular pathway of mitochondrial preprotein import through the TOM-TIM23 supercomplex.线粒体前体蛋白通过TOM-TIM23超复合物导入的分子途径。
Nat Struct Mol Biol. 2023 Dec;30(12):1996-2008. doi: 10.1038/s41594-023-01103-7. Epub 2023 Sep 11.
4
SIRT3 ameliorates diabetes-associated cognitive dysfunction via regulating mitochondria-associated ER membranes.SIRT3 通过调节线粒体相关内质网膜改善糖尿病相关认知功能障碍。
J Transl Med. 2023 Jul 22;21(1):494. doi: 10.1186/s12967-023-04246-9.
5
Attenuation of amyloid-β-induced mitochondrial dysfunction by active components of anthocyanins in HT22 neuronal cells.花青素活性成分对HT22神经细胞中β-淀粉样蛋白诱导的线粒体功能障碍的减轻作用。
MedComm (2020). 2023 Jun 19;4(4):e301. doi: 10.1002/mco2.301. eCollection 2023 Aug.
6
Aducanumab for the treatment of Alzheimer's disease: a systematic review.阿杜卡奴单抗治疗阿尔茨海默病的系统评价。
Psychogeriatrics. 2023 May;23(3):512-522. doi: 10.1111/psyg.12944. Epub 2023 Feb 12.
7
Lecanemab in Early Alzheimer's Disease.早期阿尔茨海默病中的lecanemab
N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29.
8
Lecanemab, Aducanumab, and Gantenerumab - Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer's Disease.仑卡奈单抗、阿杜卡玛单抗和加内替单抗——对不同形式的淀粉样蛋白-β的结合谱可能解释了阿尔茨海默病临床试验中的疗效和副作用。
Neurotherapeutics. 2023 Jan;20(1):195-206. doi: 10.1007/s13311-022-01308-6. Epub 2022 Oct 17.
9
The Mitochondrial Unfolded Protein Response: A Novel Protective Pathway Targeting Cardiomyocytes.线粒体未折叠蛋白反应:一种针对心肌细胞的新型保护途径。
Oxid Med Cell Longev. 2022 Sep 21;2022:6430342. doi: 10.1155/2022/6430342. eCollection 2022.
10
CEND1 deficiency induces mitochondrial dysfunction and cognitive impairment in Alzheimer's disease.CEND1 缺乏导致阿尔茨海默病中线粒体功能障碍和认知障碍。
Cell Death Differ. 2022 Dec;29(12):2417-2428. doi: 10.1038/s41418-022-01027-7. Epub 2022 Jun 22.